Editas Medicine Cash from Investing (TTM) Trends

Editas Medicine Inc (EDIT)

5.36 +0.14 (+2.68%) USD | NASDAQ | Apr 26, 13:52

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-3.731M
September 30, 2023	-94.10M
June 30, 2023	97.95M
March 31, 2023	80.96M
December 31, 2022	114.07M
September 30, 2022	118.76M
June 30, 2022	-10.13M
March 31, 2022	-1.339M
December 31, 2021	-54.47M
September 30, 2021	-140.52M
June 30, 2021	-253.12M
March 31, 2021	-183.74M
December 31, 2020	-140.52M
September 30, 2020	-23.81M
June 30, 2020	6.153M
March 31, 2020	8.09M
December 31, 2019	12.25M

Date	Value
September 30, 2019	-4.17M
June 30, 2019	104.51M
March 31, 2019	-43.28M
December 31, 2018	-53.09M
September 30, 2018	-17.80M
June 30, 2018	-33.03M
March 31, 2018	-142.33M
December 31, 2017	-183.81M
September 30, 2017	-209.52M
June 30, 2017	-181.39M
March 31, 2017	-1.567M
December 31, 2016	-3.473M
September 30, 2016	-4.837M
June 30, 2016	-4.314M
March 31, 2016	-3.688M
December 31, 2015	-1.431M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-253.12M

Minimum

Jun 2021

118.76M

Maximum

Sep 2022

-19.31M

Average

-3.731M

Median

Dec 2023

Cash from Investing (TTM) Benchmarks